Dr Walford said she did not know the replacement of concentrates with cryoprecipitate was not feasible.
Linked evidence
Chronology Information
Date:
Chapter/issue
Blood Products and Addressing Risk: Regulation of Commercial Factor Concentrates
Key Person(s)
Dr Diana Walford